Shares of Avanos Medical, Inc. (NYSE:AVNS - Get Free Report) traded down 6.3% during mid-day trading on Tuesday . The stock traded as low as $15.53 and last traded at $15.52. 155,285 shares changed hands during mid-day trading, a decline of 71% from the average session volume of 544,062 shares. The stock had previously closed at $16.57.
Analyst Upgrades and Downgrades
Separately, StockNews.com cut Avanos Medical from a "strong-buy" rating to a "buy" rating in a report on Sunday, November 3rd.
Check Out Our Latest Report on AVNS
Avanos Medical Trading Up 0.0 %
The firm has a market cap of $711.78 million, a price-to-earnings ratio of 45.55 and a beta of 0.98. The company has a fifty day moving average price of $16.22 and a 200-day moving average price of $19.87. The company has a current ratio of 2.22, a quick ratio of 1.46 and a debt-to-equity ratio of 0.12.
Hedge Funds Weigh In On Avanos Medical
Institutional investors and hedge funds have recently modified their holdings of the stock. FMR LLC lifted its holdings in shares of Avanos Medical by 34.6% in the 3rd quarter. FMR LLC now owns 133,844 shares of the company's stock valued at $3,216,000 after buying an additional 34,421 shares during the period. Barclays PLC increased its stake in shares of Avanos Medical by 446.2% in the 3rd quarter. Barclays PLC now owns 96,194 shares of the company's stock valued at $2,311,000 after purchasing an additional 78,583 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its stake in shares of Avanos Medical by 12.0% in the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 108,470 shares of the company's stock valued at $2,607,000 after purchasing an additional 11,613 shares in the last quarter. JPMorgan Chase & Co. increased its stake in shares of Avanos Medical by 6.9% in the 3rd quarter. JPMorgan Chase & Co. now owns 69,571 shares of the company's stock valued at $1,672,000 after purchasing an additional 4,472 shares in the last quarter. Finally, Jane Street Group LLC increased its stake in shares of Avanos Medical by 35.8% in the 3rd quarter. Jane Street Group LLC now owns 65,650 shares of the company's stock valued at $1,578,000 after purchasing an additional 17,306 shares in the last quarter. Institutional investors and hedge funds own 95.17% of the company's stock.
About Avanos Medical
(
Get Free Report)
Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.
Further Reading
Before you consider Avanos Medical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Avanos Medical wasn't on the list.
While Avanos Medical currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
